We are live on ! Find out more
PALI icon

Palisade Bio
PALI

18 hedge funds and large institutions have $395K invested in Palisade Bio in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 3

0% more funds holding

Funds holding: 18 → 18 (0)

0% less ownership

Funds ownership: 0.01% → 0.01% (-0%)

0% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 4

58% less capital invested

Capital invested by funds: $930K → $395K (-$535K)

Holders
18
Holders Change
–
Holders Change %
0%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
5
Reduced
3
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SIG
Sargent Investment Group
Maryland
+$70.8K
2
PAG
Private Advisor Group
New Jersey
+$21.7K
3
TRCT
Tower Research Capital (TRC)
New York
+$15.9K
4
FAT
First American Trust
California
+$13K
5
Millennium Management
Millennium Management
New York
+$12K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$74K
2
Jane Street
Jane Street
New York
-$38K
3
Two Sigma Investments
Two Sigma Investments
New York
-$23K
4
BlackRock
BlackRock
New York
-$13.5K
5
TSS
Two Sigma Securities
New York
-$2.41K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$110K – – –
SIG
2
Sargent Investment Group
Maryland
$98K +$70.8K +147 +85%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$53K +$1.93K +4 +2%
SWIG
4
Strategic Wealth Investment Group
Kentucky
$22K – – –
Renaissance Technologies
5
Renaissance Technologies
New York
$14K +$8.67K +18 +64%
PAG
6
Private Advisor Group
New Jersey
$14K +$21.7K +45 New
TSS
7
Two Sigma Securities
New York
$12K -$2.41K -5 -11%
State Street
8
State Street
Massachusetts
$12K – – –
TRCT
9
Tower Research Capital (TRC)
New York
$12K +$15.9K +33 +471%
Northern Trust
10
Northern Trust
Illinois
$9K – – –
UBS Group
11
UBS Group
Switzerland
$9K +$8.67K +18 +164%
Millennium Management
12
Millennium Management
New York
$8K +$12K +25 New
FAT
13
First American Trust
California
$8K +$13K +27 New
Wells Fargo
14
Wells Fargo
California
$7K – – –
BSW
15
Buckingham Strategic Wealth
Missouri
$4K +$7.22K +15 New
Morgan Stanley
16
Morgan Stanley
New York
$3K – – –
Citadel Advisors
17
Citadel Advisors
Florida
– -$74K -93 Closed
Jane Street
18
Jane Street
New York
– -$38K -48 Closed
Two Sigma Investments
19
Two Sigma Investments
New York
– -$23K -29 Closed
BlackRock
20
BlackRock
New York
– -$13.5K -28 -97%
Osaic Holdings
21
Osaic Holdings
Arizona
– -$1.93K -4 -80%
JP Morgan Chase
22
JP Morgan Chase
New York
– -$1K -1 Closed

PALI Hedge Fund Activity: Q2 2022 in Review

18 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Palisade Bio (PALI) for Q2 2022, worth a combined $395K — down 58% from $930K a quarter earlier.

Fund positioning in PALI was balanced in Q2 2022: 4 funds opened new positions, 4 closed out, 5 added to existing stakes and 3 trimmed.

The largest buyer was Sargent Investment Group, adding an estimated $70.8K. The largest seller was Citadel Advisors, exiting entirely with an estimated $74K sold.

  • 18 institutional investors held Palisade Bio (PALI) as of Q2 2022, unchanged from Q1 2022.
  • Funds reported $395K of Palisade Bio stock for Q2 2022, down 58% quarter-over-quarter.
  • 4 funds opened new Palisade Bio positions in Q2 2022 and 4 closed out, a net change of 0 holders.
  • The largest Palisade Bio buyer in Q2 2022 was Sargent Investment Group, an estimated $70.8K added.
  • The largest Palisade Bio seller in Q2 2022 was Citadel Advisors, an estimated $74K sold.

Based on aggregated 13F filings for Q2 2022.